Sumitomo Mitsui Financial Group, Inc. Abb Vie Inc. Transaction History
Sumitomo Mitsui Financial Group, Inc.
- $5.4 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Financial Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Sumitomo Mitsui Financial Group, Inc. holds 1,230 shares of ABBV stock, worth $244,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,230Holding current value
$244,327% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,246Shares Held
1.28BCall Options Held
16.2MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA177MShares$35.2 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.17 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $351B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...